View in EDS HTML Full Text PDF Full Text

Final safety and efficacy results from the CPX-351 early access program for older patients with high-risk or secondary acute myeloid leukemia.

Saved in:
Bibliographic Details
Title: Final safety and efficacy results from the CPX-351 early access program for older patients with high-risk or secondary acute myeloid leukemia.
Authors: Roboz GJ; Weill Cornell Medicine and the New York Presbyterian Hospital, New York, NY, USA., Larson ML; Rush University Medical Center, Chicago, IL, USA., Rubenstein SE; Franciscan Health, Indianapolis, IN, USA., Solomon SR; The Leukemia Program at Northside Hospital Cancer Center Institute, Atlanta, GA, USA., Schiller GJ; David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., An Q; Jazz Pharmaceuticals, Palo Alto, CA, USA., Chiarella M; Jazz Pharmaceuticals, Palo Alto, CA, USA., Louie AC; Jazz Pharmaceuticals, Palo Alto, CA, USA., Lin TL; University of Kansas Medical Center, Kansas City, KS, USA.
Source: Leukemia & lymphoma [Leuk Lymphoma] 2020 May; Vol. 61 (5), pp. 1188-1194. Date of Electronic Publication: 2020 Feb 26.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32102577
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Final safety and efficacy results from the CPX-351 early access program for older patients with high-risk or secondary acute myeloid leukemia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Roboz+GJ%22">Roboz GJ</searchLink>; Weill Cornell Medicine and the New York Presbyterian Hospital, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Larson+ML%22">Larson ML</searchLink>; Rush University Medical Center, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Rubenstein+SE%22">Rubenstein SE</searchLink>; Franciscan Health, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Solomon+SR%22">Solomon SR</searchLink>; The Leukemia Program at Northside Hospital Cancer Center Institute, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Schiller+GJ%22">Schiller GJ</searchLink>; David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22An+Q%22">An Q</searchLink>; Jazz Pharmaceuticals, Palo Alto, CA, USA.<br /><searchLink fieldCode="AU" term="%22Chiarella+M%22">Chiarella M</searchLink>; Jazz Pharmaceuticals, Palo Alto, CA, USA.<br /><searchLink fieldCode="AU" term="%22Louie+AC%22">Louie AC</searchLink>; Jazz Pharmaceuticals, Palo Alto, CA, USA.<br /><searchLink fieldCode="AU" term="%22Lin+TL%22">Lin TL</searchLink>; University of Kansas Medical Center, Kansas City, KS, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229007422%22">Leukemia & lymphoma</searchLink> [Leuk Lymphoma] 2020 May; Vol. 61 (5), pp. 1188-1194. <i>Date of Electronic Publication: </i>2020 Feb 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9007422 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1029-2403 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210268022%22">10268022 </searchLink><i>NLM ISO Abbreviation: </i>Leuk Lymphoma <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32102577
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/10428194.2020.1725503
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1188
    Titles:
      – TitleFull: Final safety and efficacy results from the CPX-351 early access program for older patients with high-risk or secondary acute myeloid leukemia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Roboz GJ
      – PersonEntity:
          Name:
            NameFull: Larson ML
      – PersonEntity:
          Name:
            NameFull: Rubenstein SE
      – PersonEntity:
          Name:
            NameFull: Solomon SR
      – PersonEntity:
          Name:
            NameFull: Schiller GJ
      – PersonEntity:
          Name:
            NameFull: An Q
      – PersonEntity:
          Name:
            NameFull: Chiarella M
      – PersonEntity:
          Name:
            NameFull: Louie AC
      – PersonEntity:
          Name:
            NameFull: Lin TL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2020 May
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1029-2403
          Numbering:
            – Type: volume
              Value: 61
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Leukemia & lymphoma
              Type: main
ResultId 1